A novel renal epithelial cell in vitro assay to assess Candida albicans virulence

Virulence

Volumn 5, Issue 2, 2014, Pages 286-296

  Szabo, Edina K ^a   MacCallum, Donna M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Candida albicans; Infection model; Innate immunity; Renal epithelium; Virulence

Indexed keywords

CXCL3 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL ASSAY; CELL DAMAGE; CELL INTERACTION; CONTROLLED STUDY; FUNGAL VIRULENCE; FUNGUS HYPHAE; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY;

CANDIDA ALBICANS; INFECTION MODEL; INNATE IMMUNITY; RENAL EPITHELIUM; VIRULENCE;

ANIMALS; CANDIDA ALBICANS; CELL SURVIVAL; CHEMOKINE CXCL1; CHEMOKINE CXCL2; CYTOLOGICAL TECHNIQUES; EPITHELIAL CELLS; MICE; VIRULENCE;

EID: 84897883892     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.27046     Document Type: Article

References (85)

1. Scanlan PD, Marchesi JR. Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and-independent analysis of faeces. ISME J 2008; 2:1183-93; PMID:18670396; http://dx.doi.org/10.1038/ ismej.2008.76
2. Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, Harrison LH, Seaberg EC, Hajjeh RA, Teutsch SM. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005; 26:540-7; PMID:16018429; http://dx.doi.org/10.1086/502581
3. Chalmers CM, Bal AM. Management of fungal infections in the intensive care unit: a survey of UK practice. Br J Anaesth 2011; 106:827-31; PMID:21504935; http://dx.doi.org/10.1093/bja/ aer089
4. Das I, Nightingale P, Patel M, Jumaa P. Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK. Int J Infect Dis 2011; 15:e759-63; PMID:21840742; http://dx.doi.org/10.1016/j.ijid.2011.06.006
5. Schelenz S, Barnes RA, Kibbler CC, Jones BL, Denning DW. Standards of care for patients with invasive fungal infections within the United Kingdom: a national audit. J Infect 2009; 58:145-53; PMID:19185349; http://dx.doi.org/10.1016/j. jinf.2008.12.006
6. MacCallum DM. Candida infections and modelling disease. In: Ashbee R, Bignell EM, editors. The yeast handbook: pathogenic yeasts. Springer Berlin Heidelberg; 2010. p. 41-67
7. McMillan MD, Cowell VM. Effects of chronic Candida albicans in the hamster cheek pouch. Oral Surg Oral Med Oral Pathol 1992; 74:492-8; PMID:1408027; http://dx.doi. org/10.1016/0030-4220(92)90302-7
8. de Bernardis F, Santoni G, Boccanera M, Spreghini E, Adriani D, Morelli L, Cassone A. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans. Infect Immun 2000; 68:3297-304; PMID:10816477; http://dx.doi.org/10.1128/IAI.68.6.3297-3304.2000
9. Balish E, Wagner RD, Vazquez-Torres A, Jones-Carson J, Pierson C, Warner T. Mucosal and systemic candidiasis in IL-8Rh-/-BALB/c mice. J Leukoc Biol 1999; 66:144-50; PMID:10411002
10. Clemons KV, Gonzalez GM, Singh G, Imai J, Espiritu M, Parmar R, Stevens DA. Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs. Antimicrob Agents Chemother 2006; 50:2650-7; PMID:16870754; http://dx.doi.org/10.1128/AAC.00530-06
11. Savage DC, Dubos RJ. Localization of indigenous yeast in the murine stomach. J Bacteriol 1967; 94:1811-6; PMID:16562156
12. Samaranayake YH, Samaranayake LP. Experimental oral candidiasis in animal models. Clin Microbiol Rev 2001; 14:398-429; PMID:11292645; http:// dx.doi.org/10.1128/CMR.14.2.398-429.2001
13. Russell WMS, Burch RL. The Principles of Humane Experimental Technique. London: Methuen, 1959.
14. Ohnemus U, Willers C, Bubenheim M, Horstkotte MA, Houdek P, Fischer F, Schmage P, Moll I, Brandner JM. An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents. Mycoses 2008; 51:21-9; PMID:18076591
15. Naglik JR, Moyes D, Makwana J, Kanzaria P, Tsichlaki E, Weindl G, Tappuni AR, Rodgers CA, Woodman AJ, Challacombe SJ, et al. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology 2008; 154:3266-80; PMID:18957581; http://dx.doi.org/10.1099/ mic.0.2008/022293-0
16. Bahri R, Saidane-Mosbahi D, Rouabhia M. Candida famata modulates toll-like receptor, beta-defensin, and proinflammatory cytokine expression by normal human epithelial cells. J Cell Physiol 2010; 222:209-18; PMID:19780045; http://dx.doi.org/10.1002/ jcp.21939
17. Dalle F, Wächtler B, L'Ollivier C, Holland G, Bannert N, Wilson D, Labruère C, Bonnin A, Hube B. Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell Microbiol 2010; 12:248-71; PMID:19863559; http://dx.doi.org/10.1111/j.1462-5822.2009.01394.x
18. Semlin L, Schäfer-Korting M, Borelli C, Korting HC. In vitro models for human skin disease. Drug Discov Today 2011; 16:132-9; PMID:21146629; http://dx.doi.org/10.1016/j.drudis.2010.12.001
19. Weindl G, Wagener J, Schaller M. Epithelial cells and innate antifungal defense. J Dent Res 2010; 89:666-75; PMID:20395411; http://dx.doi. org/10.1177/0022034510368784
20. Schaller M, Boeld U, Oberbauer S, Hamm G, Hube B, Korting HC. Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis. Microbiology 2004; 150:2807-13; PMID:15347740; http://dx.doi.org/10.1099/mic.0.27169-0
21. Schaller M, Schäfer W, Korting HC, Hube B. Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol 1998; 29:605-15; PMID:9720876; http://dx.doi. org/10.1046/j.1365-2958.1998.00957.x
22. Schaller M, Mailhammer R, Grassl G, Sander CA, Hube B, Korting HC. Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol 2002; 118:652-7; PMID:11918712; http:// dx.doi.org/10.1046/j.1523-1747.2002.01699.x
23. Khodavandi A, Alizadeh F, Harmal NS, Sidik SM, Othman F, Sekawi Z, Jahromi MA, Ng KP, Chong PP. Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model. FEMS Microbiol Lett 2011; 315:87-93; PMID:21204918; http:// dx.doi.org/10.1111/j.1574-6968.2010.02170.x
24. Wächtler B, Citiulo F, Jablonowski N, Förster S, Dalle F, Schaller M, Wilson D, Hube B. Candida albicansepithelial interactions: dissecting the roles of active penetration, induced endocytosis and host factors on the infection process. PLoS One 2012; 7:e36952; PMID:22606314; http://dx.doi.org/10.1371/journal. pone.0036952
25. Yadev NP, Murdoch C, Saville SP, Thornhill MH. Evaluation of tissue engineered models of the oral mucosa to investigate oral candidiasis. Microb Pathog 2011; 50:278-85; PMID:21296654; http://dx.doi. org/10.1016/j.micpath.2010.11.009
26. Dongari-Bagtzoglou A, Kashleva H. Development of a novel three-dimensional in vitro model of oral Candida infection. Microb Pathog 2006; 40:271-8; PMID:16626928; http://dx.doi.org/10.1016/j. micpath.2006.02.004
27. Hollmer C, Essmann M, Ault K, Larsen B. Adherence and blocking of Candida albicans to cultured vaginal epithelial cells: treatments to decrease adherence. Infect Dis Obstet Gynecol 2006; 2006:98218; PMID:17485817; http://dx.doi.org/10.1155/ IDOG/2006/98218
28. Orozco AS, Zhou X, Filler SG. Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection. Infect Immun 2000; 68:1134-41; PMID:10678917; http://dx.doi. org/10.1128/IAI.68.3.1134-1141.2000
29. Sanchez AA, Johnston DA, Myers C, Edwards JE Jr., Mitchell AP, Filler SG. Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro. Infect Immun 2004; 72:598-601; PMID:14688143; http://dx.doi.org/10.1128/ IAI.72.1.598-601.2004
30. Seidl K, Solis NV, Bayer AS, Hady WA, Ellison S, Klashman MC, Xiong YQ, Filler SG. Divergent responses of different endothelial cell types to infection with Candida albicans and Staphylococcus aureus. PLoS One 2012; 7:e39633; PMID:22745797; http:// dx.doi.org/10.1371/journal.pone.0039633
31. van de Veerdonk FL, Joosten LA, Devesa I, Mora-Montes HM, Kanneganti TD, Dinarello CA, van der Meer JW, Gow NA, Kullberg BJ, Netea MG. Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1beta production by the fungal pathogen Candida albicans. J Infect Dis 2009; 199:1087-96; PMID:19222370; http:// dx.doi.org/10.1086/597274
32. Mora-Montes HM, Bates S, Netea MG, Castillo L, Brand A, Buurman ET, Díaz-Jiménez DF, Jan Kullberg B, Brown AJ, Odds FC, et al. A multifunctional mannosyltransferase family in Candida albicans determines cell wall mannan structure and host-fungus interactions. J Biol Chem 2010; 285:12087-95; PMID:20164191; http://dx.doi.org/10.1074/jbc. M109.081513
33. Gow NA, Netea MG, Munro CA, Ferwerda G, Bates S, Mora-Montes HM, Walker L, Jansen T, Jacobs L, Tsoni V, et al. Immune recognition of Candida albicans beta-glucan by dectin-1. J Infect Dis 2007; 196:1565-71; PMID:18008237; http://dx.doi. org/10.1086/523110
34. Chamilos G, Lionakis MS, Lewis RE, Lopez-Ribot JL, Saville SP, Albert ND, Halder G, Kontoyiannis DP. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis 2006; 193:1014-22; PMID:16518764; http://dx.doi. org/10.1086/500950
35. Gottar M, Gobert V, Matskevich AA, Reichhart JM, Wang C, Butt TM, Belvin M, Hoffmann JA, Ferrandon D. Dual detection of fungal infections in Drosophila via recognition of glucans and sensing of virulence factors. Cell 2006; 127:1425-37; PMID:17190605; http://dx.doi.org/10.1016/j. cell.2006.10.046
36. Pukkila-Worley R, Peleg AY, Tampakakis E, Mylonakis E. Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot Cell 2009; 8:1750-8; PMID:19666778; http://dx.doi.org/10.1128/ EC.00163-09
37. Hall RA, Bates S, Lenardon MD, Maccallum DM, Wagener J, Lowman DW, Kruppa MD, Williams DL, Odds FC, Brown AJ, et al. The Mnn2 mannosyltransferase family modulates mannoprotein fibril length, immune recognition and virulence of Candida albicans. PLoS Pathog 2013; 9:e1003276; PMID:23633946; http://dx.doi.org/10.1371/journal. ppat.1003276
38. Mesa-Arango AC, Forastiero A, Bernal-Martínez L, Cuenca-Estrella M, Mellado E, Zaragoza O. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast. Med Mycol 2013; 51:461-72; PMID:23170962; http://dx.doi.org/10.3 109/13693786.2012.737031
39. Bergin D, Murphy L, Keenan J, Clynes M, Kavanagh K. Pre-exposure to yeast protects larvae of Galleria mellonella from a subsequent lethal infection by Candida albicans and is mediated by the increased expression of antimicrobial peptides. Microbes Infect 2006; 8:2105-12; PMID:16782387; http://dx.doi. org/10.1016/j.micinf.2006.03.005
40. Jacobsen ID, Grosse K, Berndt A, Hube B. Pathogenesis of Candida albicans infections in the alternative chorio-allantoic membrane chicken embryo model resembles systemic murine infections. PLoS One 2011; 6:e19741; PMID:21603634; http:// dx.doi.org/10.1371/journal.pone.0019741
41. Gow NA, Knox Y, Munro CA, Thompson WD. Infection of chick chorioallantoic membrane (CAM) as a model for invasive hyphal growth and pathogenesis of Candida albicans. Med Mycol 2003; 41:331-8; PMID:12964726; http://dx.doi.org/10.1080/136937 80310001600859
42. Walker LA, Maccallum DM, Bertram G, Gow NA, Odds FC, Brown AJ. Genome-wide analysis of Candida albicans gene expression patterns during infection of the mammalian kidney. Fungal Genet Biol 2009; 46:210-9; PMID:19032986; http:// dx.doi.org/10.1016/j.fgb.2008.10.012
43. Castillo L, MacCallum DM, Brown AJ, Gow NA, Odds FC. Differential regulation of kidney and spleen cytokine responses in mice challenged with pathology-standardized doses of Candida albicans mannosylation mutants. Infect Immun 2011; 79:146-52; PMID:21059878; http://dx.doi.org/10.1128/ IAI.01004-10
44. Lee KK, Maccallum DM, Jacobsen MD, Walker LA, Odds FC, Gow NAR, Munro CA. Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo. Antimicrob Agents Chemother 2012; 56:208-17; PMID:21986821; http://dx.doi. org/10.1128/AAC.00683-11
45. Tashiro M, Kimura S, Tateda K, Saga T, Ohno A, Ishii Y, Izumikawa K, Tashiro T, Kohno S, Yamaguchi K. Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis. Med Mycol 2012; 50:353-60; PMID:21954955; http://dx.doi.org/10.3109/136937 86.2011.610037
46. MacCallum DM. Mouse model of invasive fungal infection. Methods Mol Biol 2013; 1031:145-53; PMID:23824897; http://dx.doi. org/10.1007/978-1-62703-481-4_17
47. Szabo EK, MacCallum DM. The contribution of mouse models to our understanding of systemic candidiasis. FEMS Microbiol Lett 2011; 320:1-8; PMID:21395661; http://dx.doi. org/10.1111/j.1574-6968.2011.02262.x
48. MacCallum DM, Odds FC. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses 2005; 48:151-61; PMID:15842329; http://dx.doi. org/10.1111/j.1439-0507.2005.01121.x
49. Spellberg B, Ibrahim AS, Edwards JE Jr., Filler SG. Mice with disseminated candidiasis die of progressive sepsis. J Infect Dis 2005; 192:336-43; PMID:15962230; http://dx.doi.org/10.1086/430952
50. Ashman RB, Papadimitriou JM. Murine candidiasis. Pathogenesis and host responses in genetically distinct inbred mice. Immunol Cell Biol 1987; 65:163-71; PMID:3610217; http://dx.doi.org/10.1038/ icb.1987.18
51. MacCallum DM. Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model. FEMS Yeast Res 2009; 9:1111-22; PMID:19845042; http:// dx.doi.org/10.1111/j.1567-1364.2009.00576.x
52. MacCallum DM, Castillo L, Brown AJ, Gow NA, Odds FC. Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections. PLoS One 2009; 4:e6420; PMID:19641609; http://dx.doi. org/10.1371/journal.pone.0006420
53. Filler SG, Pfunder AS, Spellberg BJ, Spellberg JP, Edwards JE Jr. Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. Infect Immun 1996; 64:2609-17; PMID:8698486
54. Maza PK, Oliveira P, Toledo MS, Paula DMB, Takahashi HK, Straus AH, Suzuki E. Paracoccidioides brasiliensis induces secretion of IL-6 and IL-8 by lung epithelial cells. Modulation of host cytokine levels by fungal proteases. Microbes Infect 2012; 14:1077-85; PMID:22687715; http://dx.doi.org/10.1016/j. micinf.2012.05.016
55. Whiley RA, Cruchley AT, Gore C, Hagi-Pavli E. Candida albicans strain-dependent modulation of pro-inflammatory cytokine release by in vitro oral and vaginal mucosal models. Cytokine 2012; 57:89-97; PMID:22129624; http://dx.doi.org/10.1016/j. cyto.2011.10.017
56. Gerritsma JS, Hiemstra PS, Gerritsen AF, Prodjosudjadi W, Verweij CL, Van Es LA, Daha MR. Regulation and production of IL-8 by human proximal tubular epithelial cells in vitro. Clin Exp Immunol 1996; 103:289-94; PMID:8565314; http:// dx.doi.org/10.1046/j.1365-2249.1996.d01-617.x
57. Schmouder RL, Strieter RM, Wiggins RC, Chensue SW, Kunkel SL. In vitro and in vivo interleukin-8 production in human renal cortical epithelia. Kidney Int 1992; 41:191-8; PMID:1593855; http://dx.doi. org/10.1038/ki.1992.26
58. Dongari-Bagtzoglou A, Kashleva H. Candida albicans triggers interleukin-8 secretion by oral epithelial cells. Microb Pathog 2003; 34:169-77; PMID:12668140; http://dx.doi.org/10.1016/S0882-4010(03)00004-4
59. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP 3rd, Toews GB, Westwick J, Strieter RM. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest 1990; 86:1945-53; PMID:2254454; http://dx.doi.org/10.1172/ JCI114928
60. Steele C, Fidel PL Jr. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun 2002; 70:577-83; PMID:11796585; http://dx.doi. org/10.1128/IAI.70.2.577-583.2002
61. Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995; 95:55-65; PMID:7814646; http://dx.doi.org/10.1172/ JCI117676
62. van de Veerdonk FL, Marijnissen RJ, Kullberg BJ, Koenen HJ, Cheng SC, Joosten I, van den Berg WB, Williams DL, van der Meer JW, Joosten LA, et al. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009; 5:329-40; PMID:19380112; http://dx.doi. org/10.1016/j.chom.2009.02.006
63. Gersuk GM, Underhill DM, Zhu L, Marr KA. Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J Immunol 2006; 176:3717-24; PMID:16517740
64. Seider K, Brunke S, Schild L, Jablonowski N, Wilson D, Majer O, Barz D, Haas A, Kuchler K, Schaller M, et al. The facultative intracellular pathogen Candida glabrata subverts macrophage cytokine production and phagolysosome maturation. J Immunol 2011; 187:3072-86; PMID:21849684; http://dx.doi. org/10.4049/jimmunol.1003730
65. Bates S, MacCallum DM, Bertram G, Munro CA, Hughes HB, Buurman ET, Brown AJ, Odds FC, Gow NA. Candida albicans Pmr1p, a secretory pathway P-type Ca2+/Mn2+-ATPase, is required for glycosylation and virulence. J Biol Chem 2005; 280:23408-15; PMID:15843378; http://dx.doi.org/10.1074/jbc. M502162200
66. Gillum AM, Tsay EYH, Kirsch DR. Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 1984; 198:179-82; PMID:6394964; http://dx.doi. org/10.1007/BF00328721
67. Munro CA, Bates S, Buurman ET, Hughes HB, Maccallum DM, Bertram G, Atrih A, Ferguson MA, Bain JM, Brand A, et al. Mnt1p and Mnt2p of Candida albicans are partially redundant α-1,2-mannosyltransferases that participate in O-linked mannosylation and are required for adhesion and virulence. J Biol Chem 2005; 280:1051-60; PMID:15519997; http://dx.doi.org/10.1074/jbc. M411413200
68. Brand A, MacCallum DM, Brown AJ, Gow NA, Odds FC. Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus. Eukaryot Cell 2004; 3:900-9; PMID:15302823; http://dx.doi. org/10.1128/EC.3.4.900-909.2004
69. Badrane H, Cheng S, Nguyen MH, Jia HY, Zhang Z, Weisner N, Clancy CJ. Candida albicans IRS4 contributes to hyphal formation and virulence after the initial stages of disseminated candidiasis. Microbiology 2005; 151:2923-31; PMID:16151204; http://dx.doi.org/10.1099/mic.0.27998-0
70. Chiang LY, Sheppard DC, Bruno VM, Mitchell AP, Edwards JE Jr., Filler SG. Candida albicans protein kinase CK2 governs virulence during oropharyngeal candidiasis. Cell Microbiol 2007; 9:233-45; PMID:16939537; http://dx.doi. org/10.1111/j.1462-5822.2006.00784.x
71. van de Veerdonk FL, Kullberg BJ, van der Meer JW, Gow NA, Netea MG. Host-microbe interactions: innate pattern recognition of fungal pathogens. Curr Opin Microbiol 2008; 11:305-12; PMID:18602019; http://dx.doi.org/10.1016/j.mib.2008.06.002
72. Pathak E, Mayeux PR. In vitro model of sepsisinduced renal epithelial reactive nitrogen species generation. Toxicol Sci 2010; 115:475-81; http://dx.doi. org/10.1093/toxsci/kfq058; PMID:20176626
73. Li F, Palecek SP. EAP1, a Candida albicans gene involved in binding human epithelial cells. Eukaryot Cell 2003; 2:1266-73; PMID:14665461; http:// dx.doi.org/10.1128/EC.2.6.1266-1273.2003
74. Schaller M, Korting HC, Borelli C, Hamm G, Hube B. Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis. Infect Immun 2005; 73:2758-65; PMID:15845479; http://dx.doi. org/10.1128/IAI.73.5.2758-2765.2005
75. Lo HJ, Köhler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR. Nonfilamentous C. albicans mutants are avirulent. Cell 1997; 90:939-49; PMID:9298905; http://dx.doi.org/10.1016/ S0092-8674(00)80358-X
76. Zheng X, Wang Y, Wang Y. Hgc1, a novel hyphaspecific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J 2004; 23:1845-56; PMID:15071502; http://dx.doi. org/10.1038/sj.emboj.7600195
77. Netea MG, Gow NA, Munro CA, Bates S, Collins C, Ferwerda G, Hobson RP, Bertram G, Hughes HB, Jansen T, et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest 2006; 116:1642-50; PMID:16710478; http://dx.doi. org/10.1172/JCI27114
78. Gantner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 2005; 24:1277-86; PMID:15729357; http://dx.doi.org/10.1038/ sj.emboj.7600594
79. McColl SR, Clark-Lewis I. Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists. J Immunol 1999; 163:2829-35; PMID:10453028
80. Naglik JR, Moyes D. Epithelial cell innate response to Candida albicans. Adv Dent Res 2011; 23:50-5; PMID:21441481; http://dx.doi. org/10.1177/0022034511399285
81. Filler SG, Ibe BO, Luckett PM, Raj JU, Edwards JE Jr. Candida albicans stimulates endothelial cell eicosanoid production. J Infect Dis 1991; 164:928-35; PMID:1940471; http://dx.doi.org/10.1093/ infdis/164.5.928
82. MacCallum DM, Castillo L, Nather K, Munro CA, Brown AJ, Gow NA, Odds FC. Property differences among the four major Candida albicans strain clades. Eukaryot Cell 2009; 8:373-87; PMID:19151328; http://dx.doi.org/10.1128/EC.00387-08
83. Marakalala MJ, Vautier S, Potrykus J, Walker LA, Shepardson KM, Hopke A, Mora-Montes HM, Kerrigan A, Netea MG, Murray GI, et al. Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1. PLoS Pathog 2013; 9:e1003315; PMID:23637604; http://dx.doi. org/10.1371/journal.ppat.1003315
84. Martchenko M, Alarco AM, Harcus D, Whiteway M. Superoxide dismutases in Candida albicans: transcriptional regulation and functional characterization of the hyphal-induced SOD5 gene. Mol Biol Cell 2004; 15:456-67; PMID:14617819; http://dx.doi. org/10.1091/mbc.E03-03-0179
85. Fradin C, De Groot P, MacCallum D, Schaller M, Klis F, Odds FC, Hube B. Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol Microbiol 2005; 56:397-415; PMID:15813733; http://dx.doi.org/10.1111/j.1365-2958.2005.04557.x